Ipca Laboratories Ltd

NSE: IPCALAB · BSE: 524494 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1,946.90
Market cap: ₹49,394 Cr
Revenue (annual): ₹9,646 Cr
Net profit (annual): ₹1,141 Cr
P/E (TTM): 37.7×Sector 47.4×
Promoter holding: 44.72%+0.00% QoQ
FII holding: 10.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Merger & Restructuring 2 Earnings Call 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Partnership 1 Management Change 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

26 Jun 2026 13:24 IST NSE

Merger & Restructuring

Ipca Laboratories Merger & Restructuring Worth ₹7,431 Cr

Ipca Laboratories approved the merger of Krebs Biochemicals with a 7:200 swap ratio. The move aims to integrate fermentation-based API manufacturing and secure key supply chains.

Value: ₹7,431 Cr

Read the filing ↗

26 Jun 2026 13:12 IST NSE

Merger & Restructuring

Ipca Laboratories Merger & Restructuring

Ipca Laboratories approved the amalgamation of Krebs Biochemicals & Industries Ltd. The merger aims to optimize costs and secure API supplies.

Read the filing ↗